Key facts
- Notable investors include Lapam Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Senmiao Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Senmiao Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Senmiao Biotechnology
Manufacturer of biopharmaceutical products intended to advance targeted immune-modulation therapies. The company offers TLR7/8 agonist drug candidates, advanced preclinical research, and veterinary biotechnology expertise, enabling pharmaceutical and animal health sectors to accelerate therapeutic development and improve treatment outcomes.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Senmiao Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Senmiao Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Senmiao Biotechnology in its N-PORT filings yet. We sweep new filings monthly.